Short-term bisphosphonate treatment reduces serum 25(OH) vitamin D(3) and alters values of parathyroid hormone, pentosidine, and bone metabolic markers

This study aimed to clarify the effects of short-term bisphosphonate (BP) administration in Japanese osteoporotic patients retrospectively. Daily minodronate (MIN) at 1 mg/day (MIN group) or weekly risedronate (RIS) at 17.5 mg/week (RIS group) was primarily prescribed for each patient. We analyzed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamimura, Mikio, Uchiyama, Shigeharu, Nakamura, Yukio, Ikegami, Shota, Mukaiyama, Keijiro, Kato, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315201/
https://www.ncbi.nlm.nih.gov/pubmed/28243105
http://dx.doi.org/10.2147/TCRM.S120749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315201/
https://www.ncbi.nlm.nih.gov/pubmed/28243105
http://dx.doi.org/10.2147/TCRM.S120749

Ejemplares similares